Status
Conditions
Treatments
About
The Campbell Score is a blood based means of assessing molecules believed to be associated with suicidal ideation and in some cases successful suicide.
The current clinical trial will assess the Campbell Score in 3 groups:
Group 1: 10 patients with no personal or family psychiatric history and no suicide attempts.
Group 2: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item >2) and reported low acquired capability for suicide (Acquired Capability for Suicide Scale <20).
Group 3: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item >2) and reported high acquired capability for suicide (Acquired Capability for Suicide Scale >60).
The goal of the study is to confirm efficacy of Campbell Score in identifying patients with high suicidal ideation potential.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
30 participants in 3 patient groups
Loading...
Central trial contact
Famela Ramos
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal